To quote Abraham Lincoln, "we cannot escape history." Not evenin the pages of a medical journal devoted to the elucidationof the scientific basis of disease can we do so. In this issueof the Journal, Hayflick et al. (pages 3340) report onthe genetic, clinical, and radiographic delineation of HallervordenSpatzsyndrome. Mutations in the gene encoding pantothenate kinase2 (PANK2), a key enzyme in the biosynthesis of coenzyme A, arecorrelated with phenotypic features observed in both classicand atypical cases of HallervordenSpatz syndrome. Theirreport is a prototypical example of the precision of the "scalpel". . . [Full Text of this Article]
Source Information
From the Department of Neurology and Neurosurgery and the Department of Pediatrics, McGill University, and the Division of Pediatric Neurology, Montreal Children's HospitalMcGill University Health Center all in Montreal.
Emmett, M.
(2007). On Wegener and the ACCP. Chest
132: 2066-2066
[Full Text]
Woywodt, A., Matteson, E. L.
(2006). Wegener's granulomatosis--probing the untold past of the man behind the eponym. Rheumatology (Oxford)
45: 1303-1306
[Full Text]
Fox, R. J.
(2006). Defending eponyms.. Arch Neurol
63: 628-628
[Full Text]
Albin, R. L., Daroff, R. B., Griggs, R. C.
(2005). Report from the Neurology Scientific Integrity Advisor: Year 1. Neurology
65: 781-781
[Full Text]
Leach, J. P., Geiderman, J. M., Shevell, M.
(2003). Hallervorden and History. NEJM
348: 1725-1726
[Full Text]